{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:08:37Z","timestamp":1778648917834,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08071-8","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:49:29Z","timestamp":1775040569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumour necrosis factor receptor-associated factor 7 drives leukaemogenesis through the TWIST1-P2RX1-Ca2+ axis in a mouse model of acute myeloid leukaemia"],"prefix":"10.1186","volume":"24","author":[{"given":"Cuijuan","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7892-4143","authenticated-orcid":false,"given":"Xiaotong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"12","key":"8071_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136\u201352.","journal-title":"N Engl J Med"},{"issue":"4","key":"8071_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2020.10.001","volume":"27","author":"R Culp-Hill","year":"2021","unstructured":"Culp-Hill R, D\u2019Alessandro A, Pietras EM. Extinguishing the embers: targeting AML metabolism. Trends Mol Med. 2021;27(4):332\u201344.","journal-title":"Trends Mol Med"},{"issue":"10147","key":"8071_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE. Acute myeloid Leukaemia. Lancet. 2018;392(10147):593\u2013606.","journal-title":"Lancet"},{"issue":"11","key":"8071_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20(11):1242\u201353.","journal-title":"Nat Med"},{"issue":"4","key":"8071_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.devcel.2009.04.001","volume":"16","author":"A Adhikari","year":"2009","unstructured":"Adhikari A, Chen ZJ. Diversity of polyubiquitin chains. Dev Cell. 2009;16(4):485\u201386.","journal-title":"Dev Cell"},{"issue":"44","key":"8071_CR6","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.1038\/sj.onc.1204788","volume":"20","author":"JR Bradley","year":"2001","unstructured":"Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 2001;20(44):6482\u201391.","journal-title":"Oncogene"},{"issue":"18","key":"8071_CR7","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1101\/gad.12.18.2821","volume":"12","author":"RH Arch","year":"1998","unstructured":"Arch RH, Gedrich RW, Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs)-a family of adapter proteins that regulates life and death. Genes Dev. 1998;12(18):2821\u201330.","journal-title":"Genes Dev"},{"issue":"6","key":"8071_CR8","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jcp.25676","volume":"232","author":"T Zotti","year":"2017","unstructured":"Zotti T, Scudiero I, Vito P, Stilo R. The emerging role of TRAF7 in tumor development. J Cell Physiol. 2017;232(6):1233\u201338.","journal-title":"J Cell Physiol"},{"issue":"7","key":"8071_CR9","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1172\/JCI96060","volume":"128","author":"R Singh","year":"2018","unstructured":"Singh R, Karri D, Shen H, Shao J, Dasgupta S, Huang S, et al. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. J Clin Invest. 2018;128(7):3129\u201343.","journal-title":"J. Clin. Invest"},{"issue":"10","key":"8071_CR10","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1182\/blood.V100.10.3749","volume":"100","author":"G Munzert","year":"2002","unstructured":"Munzert G, Kirchner D, Stobbe H, Bergmann L, Schmid RM, Dohner H, et al. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B\/Rel-regulated inhibitors of apoptosis. Blood. 2002;100(10):3749\u201356.","journal-title":"Blood"},{"issue":"11","key":"8071_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s43018-021-00262-0","volume":"2","author":"G Wu","year":"2021","unstructured":"Wu G, Xu Y, Schultz RD, Chen H, Xie J, Deng M, et al. LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-kappaB signaling axis. Nat Cancer. 2021;2(11):1170\u201384.","journal-title":"Nat Cancer"},{"issue":"47","key":"8071_CR12","doi-asserted-by":"publisher","first-page":"16600","DOI":"10.1073\/pnas.0407541101","volume":"101","author":"JM Zapata","year":"2004","unstructured":"Zapata JM, Krajewska M, Morse HC 3rd, Choi Y, Reed JC. TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma\/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci USA. 2004;101(47):16600\u201305.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"8071_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.4049\/jimmunol.1200814","volume":"189","author":"G Perez-Chacon","year":"2012","unstructured":"Perez-Chacon G, Llobet D, Pardo C, Pindado J, Choi Y, Reed JC, et al. TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia\/small lymphocytic lymphoma in mice. J Immunol. 2012;189(2):1053\u201361.","journal-title":"J Immunol"},{"issue":"6","key":"8071_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1182\/blood-2014-10-602714","volume":"125","author":"KR Bushell","year":"2015","unstructured":"Bushell KR, Kim Y, Chan FC, Ben-Neriah S, Jenks A, Alcaide M, et al. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma. Blood. 2015;125(6):999\u20131005.","journal-title":"Blood"},{"issue":"5","key":"8071_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2011.309","volume":"26","author":"CR Moore","year":"2012","unstructured":"Moore CR, Liu Y, Shao C, Covey LR, Morse HC 3rd, Xie P. Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice. Leukemia. 2012;26(5):1122\u201327.","journal-title":"Leukemia"},{"issue":"12","key":"8071_CR16","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1080\/15548627.2019.1596492","volume":"15","author":"SH Han","year":"2019","unstructured":"Han SH, Korm S, Han YG, Choi SY, Kim SH, Chung HJ, et al. GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia. Autophagy. 2019;15(12):2076\u201390.","journal-title":"Autophagy"},{"issue":"2","key":"8071_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ni.3654","volume":"18","author":"J Fang","year":"2017","unstructured":"Fang J, Bolanos LC, Choi K, Liu X, Christie S, Akunuru S, et al. Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia. Nat Immunol. 2017;18(2):236\u201345.","journal-title":"Nat Immunol"},{"issue":"11","key":"8071_CR18","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1084\/jem.20141898","volume":"212","author":"ME Varney","year":"2015","unstructured":"Varney ME, Niederkorn M, Konno H, Matsumura T, Gohda J, Yoshida N, et al. Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of toll-like receptor-TRAF6 signaling. The J Exp Med. 2015;212(11):1967\u201385.","journal-title":"The J Exp Med"},{"issue":"2","key":"8071_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.stem.2021.12.007","volume":"29","author":"T Muto","year":"2022","unstructured":"Muto T, Guillamot M, Yeung J, Fang J, Bennett J, Nadorp B, et al. TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity. Cell STEM Cell. 2022;29(2):298\u2013314.e9.","journal-title":"Cell STEM Cell"},{"issue":"3","key":"8071_CR20","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/jcp.24011","volume":"227","author":"T Zotti","year":"2012","unstructured":"Zotti T, Vito P, Stilo R. The seventh ring: exploring TRAF7 functions. J Cell Physiol. 2012;227(3):1280\u201384.","journal-title":"J Cell Physiol"},{"key":"8071_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.canlet.2019.11.012","volume":"469","author":"H He","year":"2020","unstructured":"He H, Wu Z, Li S, Chen K, Wang D, Zou H, et al. TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression. Cancer Lett. 2020;469:380\u201389.","journal-title":"Cancer Lett"},{"issue":"11","key":"8071_CR22","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1091\/mbc.e05-08-0731","volume":"16","author":"Y Morita","year":"2005","unstructured":"Morita Y, Kanei-Ishii C, Nomura T, Ishii S. TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation. Mol Biol Cell. 2005;16(11):5433\u201344.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"8071_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-025-03363-1","volume":"44","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhou T, Zhou R, Sun W, Li Y, Zhou Q, et al. TRAF7 knockdown induces cellular senescence and synergizes with lomustine to inhibit glioma progression and recurrence. J Exp Clin Cancer Res. 2025;44(1):112.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"8071_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41420-023-01675-9","volume":"9","author":"J Ye","year":"2023","unstructured":"Ye J, Liu W, Yu X, Wu L, Chen Z, Yu Y, et al. TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK\/ERK signaling. Cell Death Discov. 2023;9(1):378.","journal-title":"Cell Death Discov"},{"issue":"16","key":"8071_CR25","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1158\/0008-5472.CAN-20-3669","volume":"81","author":"P Najm","year":"2021","unstructured":"Najm P, Zhao P, Steklov M, Sewduth RN, Baietti MF, Pandolfi S, et al. Loss-of-function mutations in TRAF7 and KLF4 cooperatively activate RAS-Like GTPase signaling and promote meningioma development. Cancer Res. 2021;81(16):4218\u201329.","journal-title":"Cancer Res"},{"issue":"3","key":"8071_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/10799893.2011.563311","volume":"31","author":"JK Huang","year":"2011","unstructured":"Huang JK, Chou CT, Chang HT, Shu SS, Kuo CC, Tsai JY, et al. Effect of thapsigargin on Ca(2)+ fluxes and viability in human prostate cancer cells. J Recept Signal Transduct Res. 2011;31(3):247\u201355.","journal-title":"J Recept Signal Transduct Res"},{"key":"8071_CR27","doi-asserted-by":"publisher","first-page":"102900","DOI":"10.1016\/j.redox.2023.102900","volume":"67","author":"H Li","year":"2023","unstructured":"Li H, Wang Y, Yang F, Feng S, Chang K, Yu X, et al. Clonal MDS\/AML cells with enhanced TWIST1 expression reprogram the differentiation of bone marrow MSCs. Redox Biol. 2023;67:102900.","journal-title":"Redox Biol"},{"issue":"1","key":"8071_CR28","first-page":"84","volume":"109","author":"N Wang","year":"2024","unstructured":"Wang N, Yin J, You N, Zhu W, Guo N, Liu X, et al. Twist family BHLH transcription factor 1 is required for the maintenance of leukemia stem cell in MLL-AF9(+) acute myeloid leukemia. Haematologica. 2024;109(1):84\u201397.","journal-title":"Haematologica"},{"issue":"38","key":"8071_CR29","doi-asserted-by":"publisher","first-page":"62767","DOI":"10.18632\/oncotarget.11232","volume":"7","author":"H Tang","year":"2016","unstructured":"Tang H, Massi D, Hemmings BA, Mandala M, Hu Z, Wicki A, et al. AKT-ions with a TWIST between EMT and MET. Oncotarget. 2016;7(38):62767\u201377.","journal-title":"Oncotarget"},{"issue":"6","key":"8071_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.molcel.2016.08.009","volume":"63","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Li CF, Ruan D, Powers S, Thompson PA, Frohman MA, et al. The DNA damage transducer RNF8 facilitates cancer chemoresistance and progression through twist activation. Mol Cell. 2016;63(6):1021\u201333.","journal-title":"Mol Cell"},{"issue":"80","key":"8071_CR31","first-page":"7","volume":"15","author":"J Zhong","year":"2013","unstructured":"Zhong J, Ogura K, Wang Z, Inuzuka H. Degradation of the transcription factor twist, an oncoprotein that promotes cancer metastasis. Discov Med. 2013;15(80):7\u201315.","journal-title":"Discov Med"},{"key":"8071_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.csbj.2014.11.008","volume":"13","author":"C Oury","year":"2015","unstructured":"Oury C, Lecut C, Hego A, Wera O, Delierneux C. Purinergic control of inflammation and thrombosis: role of P2X1 receptors. Comput Struct Biotechnol J. 2015;13:106\u201310.","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"8071_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/mol.114.092528","volume":"86","author":"S Jones","year":"2014","unstructured":"Jones S, Evans RJ, Mahaut-Smith MP. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation. Mol Pharmacol. 2014;86(3):243\u201351.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"8071_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/infdis\/jiv373","volume":"213","author":"C Ledderose","year":"2016","unstructured":"Ledderose C, Bao Y, Ledderose S, Woehrle T, Heinisch M, Yip L, et al. Mitochondrial dysfunction, depleted purinergic signaling, and defective T cell vigilance and immune defense. The J Infect Dis. 2016;213(3):456\u201364.","journal-title":"The J Infect Dis"},{"key":"8071_CR35","doi-asserted-by":"publisher","first-page":"101911","DOI":"10.1016\/j.mcp.2023.101911","volume":"69","author":"L Zou","year":"2023","unstructured":"Zou L, Fang Y, He W. TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis. Mol Cell Probes. 2023;69:101911.","journal-title":"Mol Cell Probes"},{"issue":"11","key":"8071_CR36","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1084\/jem.20151323","volume":"212","author":"J Mullenders","year":"2015","unstructured":"Mullenders J, Aranda-Orgilles B, Lhoumaud P, et al. Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms. J Exp Med. 2015;212(11):1833\u201350.","journal-title":"The J Exp Med"},{"key":"8071_CR37","doi-asserted-by":"publisher","first-page":"144966","DOI":"10.1016\/j.gene.2020.144966","volume":"758","author":"H Cheng","year":"2020","unstructured":"Cheng H, Zhang N, Pati D. Cohesin subunit RAD21: from biology to disease. Gene. 2020;758:144966.","journal-title":"Gene"},{"issue":"10","key":"8071_CR38","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.2731","volume":"45","author":"A Kon","year":"2013","unstructured":"Kon A, Shih L-Y, Minamino M, et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat Genet. 2013;45(10):1232\u201337.","journal-title":"Nat Genet"},{"key":"8071_CR39","doi-asserted-by":"crossref","unstructured":"Kim W, Park DS, Nguyen SC, Yang R, Joyce EF, Jain R. A genetic screen for modifiers of cohesin clustering identifies regulators of genome folding. Sci Adv. 2026;12(5):eadx 5130.","DOI":"10.1126\/sciadv.adx5130"},{"issue":"10","key":"8071_CR40","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/life14101311","volume":"14","author":"KN Manola","year":"2024","unstructured":"Manola KN, Zachaki S, Kakosaiou K, et al. Cohesin RAD21 Gene promoter methylation in patients with acute myeloid leukemia. Life. 2024;14(10):1311.","journal-title":"Life"},{"issue":"8","key":"8071_CR41","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1074\/jbc.M111.300137","volume":"287","author":"I Scudiero","year":"2012","unstructured":"Scudiero I, Zotti T, Ferravante A, Vessichelli M, Reale C, Masone MC, et al. Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFalpha-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein. J Biol Chem. 2012;287(8):6053\u201361.","journal-title":"J Biol Chem"},{"issue":"26","key":"8071_CR42","doi-asserted-by":"publisher","first-page":"22924","DOI":"10.1074\/jbc.M110.215426","volume":"286","author":"T Zotti","year":"2011","unstructured":"Zotti T, Uva A, Ferravante A, Vessichelli M, Scudiero I, Ceccarelli M, et al. TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)\/NF-kappaB essential modulator (NEMO) and p65\/RelA protein and represses NF-kappaB activation. J Biol Chem. 2011;286(26):22924\u201333.","journal-title":"J Biol Chem"},{"issue":"1","key":"8071_CR43","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41420-021-00749-w","volume":"7","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Zhang X, Dong W. TRAF7 contributes to tumor progression by promoting ubiquitin-proteasome mediated degradation of P53 in hepatocellular carcinoma. Cell Death Discov. 2021;7(1):352.","journal-title":"Cell Death Discov"},{"issue":"7","key":"8071_CR44","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117(7):927\u201339.","journal-title":"Cell"},{"issue":"11","key":"8071_CR45","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-10-2914","volume":"71","author":"J Hong","year":"2011","unstructured":"Hong J, Zhou J, Fu J, He T, Qin J, Wang L, et al. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 2011;71(11):3980\u201390.","journal-title":"Cancer Res"},{"issue":"2","key":"8071_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ccr.2014.01.028","volume":"25","author":"J Shi","year":"2014","unstructured":"Shi J, Wang Y, Zeng L, Wu Y, Deng J, Zhang Q, et al. Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer. Cancer Cell. 2014;25(2):210\u201325.","journal-title":"Cancer Cell"},{"issue":"2","key":"8071_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41375-022-01759-y","volume":"37","author":"X He","year":"2023","unstructured":"He X, Xu Y, Huang D, Yu Z, Yu J, Xie L, et al. P2X1 enhances leukemogenesis through PBX3-BCAT1 pathways. Leukemia. 2023;37(2):265\u201375.","journal-title":"Leukemia"},{"issue":"3","key":"8071_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11302-016-9510-y","volume":"12","author":"C Ledderose","year":"2016","unstructured":"Ledderose C, Woehrle T, Ledderose S, Strasser K, Seist R, Bao Y, et al. Cutting off the power: inhibition of leukemia cell growth by pausing basal ATP release and P2X receptor signaling? Purinergic Signal. 2016;12(3):439\u201351.","journal-title":"Purinergic Signal"},{"key":"8071_CR49","doi-asserted-by":"publisher","first-page":"104901","DOI":"10.1016\/j.cellimm.2024.104901","volume":"408","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang F, Liu Z, Li M, Wu G, Li H. P2RX1-blocked neutrophils induce CD8+ T cell dysfunction and affect the immune escape of gastric cancer cells. Cell Immunol. 2025;408:104901.","journal-title":"Cell Immunol"},{"key":"8071_CR50","doi-asserted-by":"crossref","unstructured":"Wu Z, Zheng S, Li M, Zhang X, Zheng W, Wang P, et al. Targeting CaMKII\u03b4 overcomes therapy resistance in acute myeloid leukemia by suppressing STAT3\/CDK6\/BCL-2 survival axis. J Leukoc Biol. 2025.","DOI":"10.1093\/jleuko\/qiaf184"},{"key":"8071_CR51","doi-asserted-by":"crossref","unstructured":"Srinivasan D, Balakrishnan R, Chauhan A, Kumar J, Girija DM, Shrestha R, et al. Epithelial-mesenchymal transition in cancer: insights into therapeutic targets and clinical implications. MedComm. 2025;6(9):e70333.","DOI":"10.1002\/mco2.70333"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08071-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:18:38Z","timestamp":1778645918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08071-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8071"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08071-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments with primary samples were carried out in accordance with the ethical principles for medical research and approved by the Ethics Committee of Institute of Haematology and Blood Diseases Hospital (approval number: CIFMS2023004-EC-2). The animal experiments were conducted strictly in compliance with the animal care guidelines approved by the Institutional Animal Care and Use Committees of the SKLEH (approval number: IHCAMS-DWLL-NSFC2023016-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"668"}}